FDA-Approved Safe Dosages of Pantoprazole for Different Age Groups
The FDA-approved safe dosage of pantoprazole varies by age group, with 40 mg daily for adults, 20-40 mg daily for adolescents 12-16 years, 20-40 mg daily for children 6-11 years, and no FDA approval for children under 5 years of age. 1
Adult Dosing (≥16 years)
- Standard adult dosage is 40 mg once daily for most gastric acid-related disorders 1, 2
- For elderly patients (64-76 years), the same 40 mg daily dose is recommended despite slight to moderate increases in AUC (43%) and Cmax (26%) compared to younger adults 1
- For maintenance therapy of gastroesophageal reflux disease (GERD), 20 mg once daily is effective for most patients 3
- No dosage adjustment is needed based on gender despite modest increases in AUC and Cmax in women 1
Special Adult Populations
- Renal impairment: No dosage adjustment necessary, even in severe renal impairment or patients undergoing hemodialysis 1
- Hepatic impairment:
Pediatric Dosing
Children and adolescents 6-16 years:
- FDA-approved for GERD at doses of 20 mg or 40 mg once daily 1, 4
- Pharmacokinetic studies show dose-independent (when dose-normalized) behavior similar to adults 4
- Children 6-11 years have approximately 39% higher AUC than adults at the 40 mg dose 1
- Adolescents 12-16 years have approximately 10% higher AUC than adults at the 40 mg dose 1
Children under 6 years:
Administration Considerations
- Pantoprazole can be taken without regard to timing of meals, though food may delay absorption by up to 2 hours 1
- Proton pump inhibitors like pantoprazole are equivalent at the following doses: pantoprazole 40 mg = omeprazole 20 mg = lansoprazole 30 mg = esomeprazole 20 mg = rabeprazole 20 mg 7
Drug Interactions
- Pantoprazole has fewer drug-drug interactions compared to other PPIs 2, 5
- Coadministration with clopidogrel may reduce the active metabolite of clopidogrel by approximately 14% 1
- Gastric pH changes from pantoprazole may affect absorption of other drugs requiring acidic environment for absorption 1
Safety Considerations
- Children weighing more than 40 kg should be dosed as adults 4
- Pharmacokinetic studies show no evidence of drug accumulation with multiple dosing in pediatric patients 4, 6
- Wide interindividual variability in exposure has been observed, particularly in younger children 6
Always consult the most current FDA labeling for the most up-to-date dosing recommendations, as guidelines may change over time.